We neither found significant associations between high or low PD-L1 expressers and patient overall survival in the whole brain metastasis cohort nor in the subcohorts of NSCLC and melanomas (Figure 5E) as well as in the second exclusive breast carcinoma brain metastases cohort (Supplementary Figure S1). This evidence concerns the gene CD274 and melanoma.